The National Science Foundation Division of Environmental Biology awarded a $200,000 Project Grant to the University of Florida Division of Sponsored Research under the Biological Sciences federal grant program (CFDA 47.074) to support the project "RAPID: STATISTICAL INFERENCE OF INCIDENCE OF SARS-COV-2 IN THE US USING MULTIPLE DATA STREAMS TO IDENTIFY LEVELS OF IMMUNITY AND THE IMPACT OF NON-PHARMACEUTICAL INTERVENTIONS." The one-year project beginning April 1, 2022 will integrate multiple independent data sources using statistical and mechanistic models to estimate the rate of seroreversion in SARS-CoV-2 antibody assays used in U.S. serosurveys, and determine seroprevalence and cumulative infection incidence over time by state. The models will analyze serology, case, hospitalization, and death data to provide information on SARS-CoV-2 transmission and support rapid-response infectious disease modeling capabilities.
Generated 1/6/24, 10:51 PM